News & Articles

The assay has the ability to sequence and surveil evolution of virus mutations over time and geography

This study offers new insights into high grade serous ovarian cancer that have the potential to make an impact in how patients are treated in the future

This partnership aims to offer an accelerated route to market rapid test technologies

Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test

Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall

The monthly safety report will be made public on the European Medicines Agency website

The findings come from the largest study to date to look at inflammatory markers in COVID-19

Once considered a vestigial organelle, primary cilia are now believed to have an important function in the central nervous system

The heart has a ‘natural backup pacemaker’ that can kick into action if the primary way the organ generates electrical signals fails

The test helps save on much-needed testing supplies since it allows for testing for all four viruses with one swab

The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring

SARS-CoV-2 testing is a powerful tool for curbing the COVID-19 pandemic and safely reopening schools and businesses

Opaganib demonstrated dual anti-inflammatory and antiviral activity and targets a human cell component involved in viral replication

The license from ERS expands ZeClinics CRISPR IP portfolio and increases the validity and potency of zebrafish models for the drug discovery process

International experts are joining forces to combat vaccine hesitancy by tackling its root cause

Neuroscientists can now screen over 3,000 neurons from a NeuroHTS microplate in under 30 minutes with the ImageXpress Pico Automated Cell Imaging System

Emergency Use Listing granted to AstraZeneca and Serum Institute of India enabling global access to the vaccine

Focusing on innate immunity opens way for precision medicine approaches to AD

Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR

EMD Serono senior scientist Carina Carter shares her experience with some of the latest immunoassay technology optimizing pharmacokinetics and immunogenicity assay development

RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in viral entry, and is therefore expected to be effective against emerging viral variants with mutations in the spike protein

Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection

Find out how to overcome the challenges involved with establishing reference intervals for clinical interpretation in this on-demand webinar

New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific